Sebetralstat Patent Expiration
Sebetralstat was first introduced by Kalvista Pharmaceuticals Ltd
Sebetralstat Patents
Given below is the list of patents protecting Sebetralstat, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ekterly | US11234939 | Dosage Forms Comprising A Plasma Kallikrein Inhibitor | Jan 26, 2039 | Kalvista |
| Ekterly | US11230537 | Polymorphs Of N-[(3-Fluoro-4-Methoxypyridin-2-Yl)Methyl]-3-(Methoxymethyl)-1-({4-[2-Oxopyridin-1-Yl)Methyl]Phenyl} Methyl)Pyrazole-4-Carboxamide As Iallikrein Inhibitors | Dec 25, 2037 | Kalvista |
| Ekterly | US11739068 | Polymorphs Of N-[(3-Fluoro-4-Methoxypyridin-2-Yl)Methyl]-3-(Methoxymethyl)-1-({4-[(2-Oxopyridin-1-Yl)Methyl]Phenyl}Methyl)Pyrazole-4-Carboxamide And Salts Thereof | Jun 23, 2037 | Kalvista |
| Ekterly | US10364238 | N-((Het) Arylmethyl)-Heteroaryl-Carboxamides Compounds As Plasma Kallikrein Inhibitors | Nov 26, 2035 | Kalvista |
| Ekterly | US10611758 | N-((Het)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors | Nov 26, 2035 | Kalvista |
| Ekterly | US11001578 | N-((Het)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Plasma Kallikrein Inhibitors | Nov 26, 2035 | Kalvista |
| Ekterly | US11084809 | N-((Het)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors | Nov 26, 2035 | Kalvista |
| Ekterly | US11198691 | N-((Het)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors | Nov 26, 2035 | Kalvista |
Sebetralstat's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List